1. Yunusa, A., Chika, A., Bello, S. O., Yahaya, A. B., & Sadiq, A. (2022). Clinical effectiveness and tolerability of phytotherapy for benign prostatic hyperplasia-A systematic review of systematic reviews. National Journal of Physiology, Pharmacy and Pharmacology, 12(4), 395-403.

2. Chika, A., Bello, S. O., Yunusa, A., Yahaya, A. B., & Sadiq, A. (2022). Ethnobotanical survey of medicinal plants used as remedies for benign prostatic hyperplasia in Sokoto North Western Nigeria. National Journal of Physiology, Pharmacy and Pharmacology, 12(4), 511-511.

3. Sani, A. A., Oricha, B. S., Etuk, E. U., & Bello, A. Y. (2017). Effect of Aqueous Extract of Guiera Senegalensis on Milk Production in Wistar Rats. Alexandria Journal for Veterinary Sciences, 53(1).

4. Bello SO, Muhammad BY, Bello AY, Ukatu AI, Ahmad BM, Adeneye AA, Cherima JY (2016). A study of the clinical effectiveness of Chloroquine in North-western Nigeria. African Journal of Malaria and Tropical Diseases, 4 (2), pp. 266-268.

5. Bello, S. O., Chika, A., & Bello, A. Y. (2010). Is Chloroquine better than Artemisinin combination therapy as first line treatment in adult Nigerians with uncomplicated malaria? a cost-effectiveanalysis. African Journal of Infectious Diseases, 4(2).

6. Artesunate plus Amodiaquine (AS+AQ) versus Artemether -Lumefantrine (AL) for the treatment of uncomplicated plasmodium falciparum malaria in Sub-Saharan Africa-A meta-analysis. African Journal of Infectious Disease. 4(2): 20 – 28.

7. Oricha, B. S., Yakubu, A., Yahaya, B. A., Yakubu, C. J., &Ekele, B. A. (2005). Breast Cancer and Food: A Quasi-epidemiological Evidence of a Role for Dietary Phytoestrogens in Northwestern Nigerian Women. International Journal of Cancer Research, 1(1), 21-24.

8. Bello, S. O., Muhammad, B. Y., Bello, A. Y., Ukatu, A. I., Ahmad, B. M., Adeneye, A. A., &Cherima, J. Y. (2005). The pattern of infection and in vivo response to Chloroquine by uncomplicated Plasmodium falciparum malaria in northwestern Nigeria. African Journal of Biotechnology, 4(1), 79-82.

9. Innovative, rapid, high-through put method for drug repurposing in pandemic-A case study of SARS-CoV-2 and COVID-19. Front Pharmacol. 14:11300828.

10. Bello, S. O., Imam, M. U., Bello, M. B., Yunusa, A., Adamu, A. A., Shuaibu, A., ... & Okoye, I. (2022). Erythromycin, Retapamulin, Pyridoxine, Folic acid, and Ivermectin dose-dependently inhibit cytopathic effect, Papain-like Protease, and MPRO of SARS-CoV-2. bioRxiv, 2022-12.